{"id":"W2136285593","doi":"10.1093/annonc/mdu186","title":"Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":false,"ca_institutions":"TRIUMF","funders":"Sanofi","keywords":"Medicine; Taxane; Epirubicin; Breast cancer; Internal medicine; Hazard ratio; Oncology; Cyclophosphamide; Surrogate endpoint; Clinical endpoint; Chemotherapy; Proportional hazards model; Chemotherapy regimen; Cancer; Clinical trial; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004101643,0.001518266,0.002929851,0.0004373986,0.0003496417,0.001597915,0.0009539525,0.001252695,0.003655975],"category_scores_gemma":[0.002626071,0.000551132,0.002710375,0.0004899409,0.0009793185,0.001022036,0.0004631212,0.003211416,0.0008199446],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001038294,"about_ca_system_score_gemma":0.001382406,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00142432,"about_ca_topic_score_gemma":0.004790004,"domain_scores_codex":[0.9990205,0.0005759572,0.0000397351,0.0001182674,0.00008363813,0.0001618719],"domain_scores_gemma":[0.9981138,0.0006612071,0.0002847893,0.0002586627,0.0001275852,0.0005539777],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9559045,0.002082451,0.003940106,0.0003412573,0.003050731,0.00004942528,0.00006979666,0.001301824,0.00434433,0.0002187578,0.001798949,0.02689783],"study_design_scores_gemma":[0.8021709,0.1442204,0.03605868,0.0001396078,0.007233306,0.0001844555,0.00009500972,0.001792751,0.002467467,0.0008141152,0.004758659,0.00006477439],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9802879,0.006921642,0.0009896883,0.001273796,0.0003226912,0.001145823,0.004522015,0.0001473458,0.004389092],"genre_scores_gemma":[0.9796023,0.00249479,0.001942055,0.001310391,0.0002712383,0.0009684923,0.007811611,0.00007438759,0.005524783],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004101643,"threshold_uncertainty_score":0.02169186,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02556996068126863,"score_gpt":0.3565985109362326,"score_spread":0.331028550254964,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}